SJ-172550|431979-47-4|-陌孚医药/Medlife

您当前的位置：

SJ-172550

目录号: PL07009 纯度: ≥98.0%

CAS No. :431979-47-4

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	SJ-172550
中文别名	MDMX小分子抑制剂(SJ-172550);化合物SJ-172550;2-(2-氯-6-乙氧基-4-((3-甲基-5-氧代-1-苯基-1H-吡唑-4(5H)-亚基)甲基)苯氧基)乙酸甲酯
英文名称	SJ-172550
英文别名	SJ 172550;2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]aceticacidmethylester;2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]-acetic acid methyl ester;SJ-172550;MLS006011707;2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]acetic acid methyl ester;STK165480;SMR004703434;methyl {2-chloro-6-ethoxy-4-[(E)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-4H-pyrazol-4-ylidene)methyl]phenoxy}acetate;CID 1317464;MDMX Antagonist, SJ-172550;CS-1226;MDMX Antagonist, SJ-172550 - CAS 431979-47-4 - Calbiochem;Acetic acid, 2-[2-chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]-, methyl ester;Methyl 2-(2-chloro-6-ethoxy-4-((3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)methyl)phenoxy)acetate;E3 ligating enzyme,Ubiquitin activating enzyme,E2 conjugating enzyme,E1/E2/E3 Enzyme,MDM-2/p53,Ubiquitin ligase,SJ172550,E1 activating enzyme,SJ 172550,SJ-172550,inhibit,Ubiquitin conjugating enzyme,Inhibitor
Cas No.	431979-47-4
分子式	C₂₂H₂₁ClN₂O₅
分子量	428.87
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情	SJ-172550是MDMX的小分子抑制剂; 与野生型p53肽竞争性结合于MDMX的EC₅₀值为5 μM。
生物活性	SJ-172550 is a small molecule inhibitor of MDMX; competes for the wild type p53 peptide binding to MDMX with an EC 50 of 5 μM.
性状	Solid
IC50 & Target[1][2]	IC50: 5 μM (MDMX)
体外研究(In Vitro)	The p53 pathway is disrupted in virtually every human tumor. SJ-172550 binds the p53-binding pocket of MDMX, thereby displacing p53. SJ-172550 binds reversibly to MDMX and effectively kills retinoblastoma cells in which the expression of MDMX is amplified. The effect of SJ-172550 is additive when combined with an MDM2 inhibitor nutlin-3a. SJ-172550 acts through a complicated mechanism in which the compound forms a covalent but reversible complex with MDMX and locks MDMX into a conformation that is unable to bind p53. The relative stability of this complex is influenced by many factors including the reducing potential of the media, the presence of aggregates. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Reed D, et al. Identification and characterization of the first small molecule inhibitor of MDMX. J Biol Chem. 2010 Apr 2;285(14):10786-96. [2]. Bista M, et al. On the mechanism of action of SJ-172550 in inhibiting the interaction of MDM4 and p53. PLoS One. 2012;7(6):e37518.

溶解度数据	In Vitro: DMSO : 33.33 mg/mL (77.72 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品